Cetuximab as Salvage Therapy in Patients With Neo Wild-type RAS/RAF Metastatic Colorectal Cancer With Liver Metastases.

NCT04189055 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Cancer Colorectal

Interventions

DRUG: Cetuximab
DRUG: Irinotecan

Sponsor

Hôpital Franco-Britannique-Fondation Cognacq-Jay